Top Markets
Coin of the day
Glanbia plc Glanbia plc

Glanbia plc

GL9
Rankning i aktier #2990
Operating globally as a prominent nutrition company, Glanbia plc specializes in... Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
Aktiekurs
$26.88
Marknadsvärde
$6.50B
Förändring (1 dag)
0.27%
Förändring (1 år)
65.13%
Land
IE
Handel Glanbia plc (GL9)
Vinst för Glanbia plc (GL9)
Vinst i 2026 TTM: 0
Enligt de senaste finansiella rapporterna från Glanbia plc är företagets nuvarande vinst 0. År 2026 hade företaget en vinst på 0, lika med vinsten år 2026 som var 0. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Glanbia plc från 2026 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
Inte tillräckligt med data för de angivna datumen.
Vinst för liknande företag eller konkurrenter
Företag Vinst Skillnad i vinst Land
$12.96B -
CH
- -
FR
- -
JP
$550.06M -
IN
- -
BR